sunitinib
PolandDrugs containing this active substance
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (stomach and intestines), metastatic renal cell carcinoma, and neuroendocrine tumors of the pancreas that are in a progressive phase or cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Egis Pharmaceuticals PLC
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Egis Pharmaceuticals PLC
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET) in the progressive phase or those that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Egis Pharmaceuticals PLC
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and neuroendocrine pancreatic tumors that are in a progressive phase and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and neuroendocrine pancreatic tumors that are in a progressive phase and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Genepharm S.A. Pharmacare Premium Ltd.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Genepharm S.A. Pharmacare Premium Ltd.
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Genepharm S.A. Pharmacare Premium Ltd.
-
The medicine is used in adults for the treatment of tumors: gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.
-
The medicine is used in adults for the treatment of tumors: gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Génériques Generis Farmacêutica, S.A.
-
The medicinal product is used in adults to treat specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: G.L. Pharma GmbH, Pharmacare Premium Ltd., Remedica Ltd
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: G.L. Pharma GmbH, Pharmacare Premium Ltd., Remedica Ltd
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumours (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumours (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: G.L. Pharma GmbH, Pharmacare Premium Ltd., Remedica Ltd
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Glenmark Pharmaceuticals s.r.o. Remedica Ltd
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Glenmark Pharmaceuticals s.r.o. Remedica Ltd
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Glenmark Pharmaceuticals s.r.o. Remedica Ltd
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L. Synthon s.r.o.
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L. Synthon s.r.o.
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumours (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumours.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. Synthon B.V. Synthon Hispania S.L. Synthon s.r.o.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicinal product is intended for adults for the treatment of cancers: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adults for the treatment of cancers: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive stage and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is intended for adults with gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01XE04
Manufacturer: Adalvo Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adults for the treatment of specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive, unresectable pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd. Remedica Ltd
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd. Remedica Ltd
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd. Remedica Ltd
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd. Remedica Ltd
-
The medicinal product is used in adults to treat specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01XE04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicinal product is used in adults for the treatment of specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that are not surgically resectable.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01XE04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adults to treat certain types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01XE04
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used in adult patients for the treatment of gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Lek Pharmaceuticals d.d., Penicillin Products Production Unit Pharmacare Premium Ltd. Remedica Ltd
-
The medicine is used in adult patients for the treatment of gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Lek Pharmaceuticals d.d., Penicillin Products Production Unit Pharmacare Premium Ltd. Remedica Ltd
-
This medicine is used in adult patients for the treatment of cancer: gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
Manufacturer: Lek Pharmaceuticals d.d., Penicillin Products Production Unit Pharmacare Premium Ltd. Remedica Ltd
-
The medicine is used in adult patients for the treatment of gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Lek Pharmaceuticals d.d., Penicillin Products Production Unit Pharmacare Premium Ltd. Remedica Ltd
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 16.7063 mg ATC: L01EX01
Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.
-
The medicine is used in adult patients for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd., Remedica Ltd, STADA Arzneimittel AG
-
The medicine is used in adult patients for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd., Remedica Ltd, STADA Arzneimittel AG
-
The medicine is used in adult patients for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd., Remedica Ltd, STADA Arzneimittel AG
-
The medicinal product is used in adult patients for the treatment of cancers: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd., Remedica Ltd, STADA Arzneimittel AG
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Vipharm S.A.
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd. Remedica Ltd
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd. Remedica Ltd
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 37.5 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd. Remedica Ltd
-
The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
Manufacturer: Pharmacare Premium Ltd. Remedica Ltd